{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:23:51Z","timestamp":1761578631528,"version":"3.41.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.mehy.2018.06.019","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T05:23:50Z","timestamp":1529472230000},"page":"59-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["How chronic administration of benzodiazepines leads to unexplained chronic illnesses: A hypothesis"],"prefix":"10.1016","volume":"118","author":[{"given":"S.","family":"LaCorte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6292","key":"10.1016\/j.mehy.2018.06.019_b0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.283.6292.643","article-title":"Withdrawal from long-term benzodiazepine treatment","volume":"283","author":"Petursson","year":"1981","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.mehy.2018.06.019_b0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0163-7258(03)00029-9","article-title":"Neuroadaptive processes in GABAergic and glutamatergic systems in benzodiazepine dependence","volume":"98","author":"Allison","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.mehy.2018.06.019_b0015","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/bmj.288.6424.1135","article-title":"Benzodiazepine withdrawal: an unfinished story","volume":"288","author":"Ashton","year":"1984","journal-title":"BMJ"},{"key":"10.1016\/j.mehy.2018.06.019_b0020","unstructured":"Burnett C (Producer), Waite J (Presenter), Lader MH (Guest). Benzodiazepines. Face the Facts. BBC Radio 4 (Radio Interview) 1999, as transcribed by Susan Bibby. Accessed from https:\/\/www.benzo.org.uk\/facefax.htm on 1-2-2018."},{"key":"10.1016\/j.mehy.2018.06.019_b0025","unstructured":"Lader MH, Ashton H, Kenny S. The benzodiazepine medical disaster [Video file] 2016. Accessed from https:\/\/vimeo.com\/188181193 on 1-10-2018."},{"issue":"5","key":"10.1016\/j.mehy.2018.06.019_b0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2015.055","article-title":"Management of benzodiazepine misuse and dependence","volume":"38","author":"Brett","year":"2015","journal-title":"Aust Prescr"},{"key":"10.1016\/j.mehy.2018.06.019_b0035","unstructured":"Pittman CM, Youngs W, Karle E. Social networking and benzodiazepine withdrawal: the realities of dependence and the necessity of support (Presentation with Slide Show at ADAA Conference) 2013. Slide show Accessed from https:\/\/adaa.org\/sites\/default\/files\/Pittman121.pdf on 1-10-2018."},{"key":"10.1016\/j.mehy.2018.06.019_b0040","unstructured":"Benzodiazepine Information Coalition, a non-profit organization that raises awareness of the potential for harm from benzodiazepine class drugs 2018. Accessed from http:\/\/www.benzoinfo.com on 2-8-2018."},{"key":"10.1016\/j.mehy.2018.06.019_b0045","unstructured":"Curle J. Common Benzodiazepine Withdrawal & Post Withdrawal Symptoms. Benzodiazepine Information Coalition 2018, Accessed from https:\/\/www.benzoinfo.com\/2017\/10\/09\/common-benzodiazepine-withdrawal-post-withdrawal-symptoms\/ on 2-8-2018."},{"issue":"1","key":"10.1016\/j.mehy.2018.06.019_b0050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0022-3565(25)20998-3","article-title":"Chronic benzodiazepine administration. Tolerance is associated with benzodiazepine receptor down-regulation and decreased gamma-aminobutyric acidA receptor function","volume":"246","author":"Miller","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.mehy.2018.06.019_b0055","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12640-017-9810-1","article-title":"NMDA receptors and NO:cGMP signaling pathway mediate the diazepam-induced sensitization to withdrawal signs in mice","volume":"33","author":"Talarek","year":"2017","journal-title":"Neurotox Res"},{"issue":"1","key":"10.1016\/j.mehy.2018.06.019_b0060","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1124\/jpet.108.144444","article-title":"Chronic benzodiazepine administration potentates high voltage-activated calcium currents in hippocampal CA1 neurons","volume":"364","author":"Xiang","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"10.1016\/j.mehy.2018.06.019_b0065","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1073\/pnas.81.10.3118","article-title":"Micromolar-affinity benzodiazepine receptors regulate voltage-sensitive calcium channels in nerve terminal preparations","volume":"81","author":"Taft","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.mehy.2018.06.019_b0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0022-3565(25)10255-3","article-title":"Chlordiazepoxide block of two types of calcium channels in neuroblastoma cells","volume":"264","author":"Reuveny","year":"1993","journal-title":"J. Pharmacol Exp Ther"},{"issue":"11","key":"10.1016\/j.mehy.2018.06.019_b0075","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1097\/00001756-199707280-00042","article-title":"Non-GABAergic effects of midazolam, diazepam and flumazenil on voltage-dependent ion currents in NG108-15 cells","volume":"8","author":"Ishizawa","year":"1997","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.mehy.2018.06.019_b0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4236\/nm.2011.21003","article-title":"An etiological model for myalgic encephalomyetlitis\/chronic fatigue syndrome","volume":"2","author":"Jason","year":"2011","journal-title":"Neurosci Med"},{"issue":"6","key":"10.1016\/j.mehy.2018.06.019_b0085","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1111\/j.1471-4159.2007.04984.x","article-title":"Up-regulation of L-type high voltage-gated calcium channel subunits by sustained exposure to 1,4- and 1,5-benzodiazepines in cerebrocortical neurons","volume":"103","author":"Katsura","year":"2007","journal-title":"J Neurochem"},{"issue":"5\u20136","key":"10.1016\/j.mehy.2018.06.019_b0090","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/FBP.0b013e3282d28f2b","volume":"18","author":"Xiang","year":"2007","journal-title":"Behav Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2018.06.019_b0095","first-page":"596","article-title":"Chronic benzodiazepine administration alters hippocaompal CA1 neuron excitability: NMDA receptor function and expression","volume":"43","author":"Van Sickle","year":"2002","journal-title":"Neuropharmacology"},{"issue":"14","key":"10.1016\/j.mehy.2018.06.019_b0100","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1073\/pnas.90.14.6889","article-title":"Diazepam dependence prevented by glutamate antagonists","volume":"90","author":"Steppuhn","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mehy.2018.06.019_b0105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pbb.2015.12.009","article-title":"Effects of NMDA antagonists on the development and expression of tolerance to diazepam-induced motor impairment in mice","volume":"142","author":"Talarek","year":"2016","journal-title":"Pharmacol Biochem Behav"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2018.06.019_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0091-3057(01)00507-X","article-title":"Pharmacodynamic and receptor binding changes during chronic lorazepam administration","volume":"69","author":"Fahey","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.mehy.2018.06.019_b0115","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/j.1476-5381.1995.tb15083.x","article-title":"Changes in benzodiazepine-GABA receptor coupling in an accumbens-habenula circuit after chronic diazepam treatment","volume":"116","author":"Brett","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2018.06.019_b0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.coph.2004.08.006","article-title":"GABAA receptor subtypes: any clues to the mechanism of benzodiazepine dependence?","volume":"5","author":"Wafford","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.mehy.2018.06.019_b0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.neuroscience.2008.08.049","article-title":"Chronic benzodiazepine-induced reduction in GABAA receptor-mediated synaptic currents in hippocampal CA1 pyramidal neurons prevented by prior nimodipine injection","volume":"157","author":"Xiang","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2018.06.019_b0130","series-title":"General and applied toxicology","first-page":"2303","article-title":"Multiple chemical sensitivity: toxicological questions and mechanisms","author":"Pall","year":"2009"},{"issue":"9\u201310","key":"10.1016\/j.mehy.2018.06.019_b0135","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0028-3908(96)00063-9","article-title":"The effects of raising intracellular calcium on synaptic GABAA receptor-channels","volume":"35","author":"De Koninck","year":"1996","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.mehy.2018.06.019_b0140","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0306-4522(94)90479-0","article-title":"Impairment of gabaa receptor function by n-methyl-D-aspartate-mediated calcium influx in isolated ca1 pyramidal cells","volume":"62","author":"Stelzer","year":"1994","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.mehy.2018.06.019_b0145","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/jcmm.12088","article-title":"Electromagnetic fields act via activation of voltage-gated calcium channels to produce beneficial or adverse effects","volume":"17","author":"Pall","year":"2013","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.mehy.2018.06.019_b0150","unstructured":"Pall ML. The NO\/ONOO(-) cycle disease, a new disease paradigm [Video file] 2014. Accessed from https:\/\/www.youtube.com\/watch?v=6A7r1gemjto on 1-7-2018."},{"key":"10.1016\/j.mehy.2018.06.019_b0155","unstructured":"Pall ML. Electromagnetic field exposures act via activation of voltage-gated calcium channels. How this leads to diverse impacts on health [Video file] 2015. Accessed from https:\/\/www.youtube.com\/watch?v=J0zBoc0cL7I on 1-7-2018."},{"issue":"1","key":"10.1016\/j.mehy.2018.06.019_b0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.mehy.2018.06.019_b0165","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0006-2952(93)90072-5","article-title":"Inhibition of nitric oxide synthesis by methylene blue","volume":"45","author":"Mayer","year":"1992","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2018.06.019_b0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0006-8993(99)01253-6","article-title":"Methylene blue inhibits hippocampal nitric oxide synthase activity in vivo","volume":"826","author":"Volke","year":"1999","journal-title":"Brain Res"},{"issue":"11","key":"10.1016\/j.mehy.2018.06.019_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027187","article-title":"Inhibition of striatal soluble guanylyl cyclase-cGMP signaling reverses basal ganglia dysfunction and akinesia in experimental Parkinsonism","volume":"6","author":"Tseng","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.mehy.2018.06.019_b0180","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0028-3908(98)00104-X","article-title":"Neuronal death induced by SIN-1 in the presence of superoxide dismutase: protection by cyclic GMP","volume":"37","author":"Moroa","year":"1998","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.mehy.2018.06.019_b0185","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1046\/j.1471-4159.2000.740633.x","article-title":"Cyclic GMP\/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line","volume":"74","author":"Yoshioka","year":"2000","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.mehy.2018.06.019_b0190","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/01.ATV.20.5.1209","article-title":"Heme oxygenase-1 is a cGMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide","volume":"20","author":"Polte","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.mehy.2018.06.019_b0195","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1046\/j.1471-4159.2002.01055.x","article-title":"Tetrahydrobiopterin deficiency increases neuronal vulnerability to hypoxia","volume":"82","author":"Delgado-Esteban","year":"2002","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.mehy.2018.06.019_b0200","doi-asserted-by":"crossref","first-page":"H1530","DOI":"10.1152\/ajpheart.00823.2007","article-title":"Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS","volume":"294","author":"Crabtree","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.mehy.2018.06.019_b0205","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.mehy.2007.01.070","article-title":"Nitric oxide synthase partial uncoupling as a key switching mechanism for the NO\/ONOO(-) cycle","volume":"69","author":"Pall","year":"2007","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2018.06.019_b0210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj2980249","article-title":"Nitric oxide synthases in mammals","volume":"298","author":"Knowles","year":"1994","journal-title":"Biochem J"},{"issue":"41","key":"10.1016\/j.mehy.2018.06.019_b0215","doi-asserted-by":"crossref","first-page":"28128","DOI":"10.1074\/jbc.M109.041483","article-title":"Critical role for tetrahydrobiopterin recycling by dihydrofolate reductase in regulation of endothelial nitric-oxide synthase coupling. Relative importance of the de novo biopterin synthesis versus salvage pathways","volume":"284","author":"Crabtree","year":"2009","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.mehy.2018.06.019_b0220","doi-asserted-by":"crossref","first-page":"22274","DOI":"10.3390\/ijms141122274","article-title":"The NO\/ONOO(-) cycle as the central cause of heart failure","volume":"14","author":"Pall","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.mehy.2018.06.019_b0225","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbadis.2015.10.016","article-title":"Increases in intracellular calcium perturb blood-brain barrier via protein kinase C-alpha and apoptosis","volume":"1862","author":"Rakkar","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"64","key":"10.1016\/j.mehy.2018.06.019_b0230","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yjmcc.2013.09.007","article-title":"Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia\/reperfusion injury","volume":"2013","author":"Braunersreuther","year":"2013","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.mehy.2018.06.019_b0235","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1054\/mehy.1998.0825","article-title":"Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome","volume":"54","author":"Pall","year":"2000","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.mehy.2018.06.019_b0240","doi-asserted-by":"crossref","first-page":"e88405","DOI":"10.1371\/journal.pone.0088405","article-title":"Regulation of NADPH oxidase 5 protein kinase C isoforms","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.mehy.2018.06.019_b0245","unstructured":"Pall ML. How can we cure NO\/ONOO(-) cycle diseases? Approaches to curing chronic fatigue syndrome\/myalgic encephalomyelitis, fibromyalgia, multiple chemical sensitivity, Gulf War syndrome and possibly many others, Townsend Letter for Doctors and Patients (2010, February\/March), 75\u201384. Accessed from http:\/\/www.townsendletter.com\/FebMarch2010\/cureNO0210.html on 12-30-2017."},{"issue":"4","key":"10.1016\/j.mehy.2018.06.019_b0250","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1523\/JNEUROSCI.4157-04.2005","article-title":"A preferential role for glycolysis in preventing the anoxic depolarization of rat hippocampal area CA1 pyramidal cells","volume":"25","author":"Allen","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.mehy.2018.06.019_b0255","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.redox.2015.08.010","article-title":"Calcium and ROS: a mutual interplay","author":"Gorlach","year":"2015","journal-title":"Redox Biol"},{"issue":"2","key":"10.1016\/j.mehy.2018.06.019_b0260","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1046\/j.1471-4159.2000.0750782.x","article-title":"Benzodiazepine-sensitive GABAA receptors limit the activity of the NMDA\/NO\/cyclic GMP pathway: a microdialysis study in the cerebellum of freely moving rats","volume":"75","author":"Fedele","year":"2000","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.mehy.2018.06.019_b0265","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.eplepsyres.2011.12.011","article-title":"Hypoxia enhances high-voltage-activated calcium currents in rat primary cortical neurons via calcineurin","volume":"99","author":"Xiang","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.mehy.2018.06.019_b0270","unstructured":"Ashton H. Benzodiazepines: how they work and how to withdrawal, 2002. Made available by benzo.org.uk. Accessed from https:\/\/www.benzo.org.uk\/manual\/bzcha03.htm on 1-3-2018."},{"issue":"2","key":"10.1016\/j.mehy.2018.06.019_b0275","first-page":"99","article-title":"The NO\/ONOO(-) cycle as the etiological mechanism of tinnitus","volume":"13","author":"Pall","year":"2007","journal-title":"Int Tinnitus J"},{"key":"10.1016\/j.mehy.2018.06.019_b0280","unstructured":"Audhya T, Pall ML, Green JA. A study of sauna therapy in myalgic encephalmoyelitis\/chronic fatigue syndrome patients shows sauna action via raised tetrahydrobiopterin and confirms three predictions of the NO\/ONOO- cycle. Townsend Letter for Doctors and Patients (November, 2013). p. 75\u201384."},{"issue":"5","key":"10.1016\/j.mehy.2018.06.019_b0285","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/00003246-200205000-00008","article-title":"Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam","volume":"30","author":"Agelink","year":"2002","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.mehy.2018.06.019_b0290","article-title":"Role of GABA receptors in the postganglionic regulation of salivation","volume":"31","author":"Lee","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2018.06.019_b0295","unstructured":"Snutch TP, Peolquin J, Matthews E, McRory JE. Molecular properties of voltage-gated calcium channels. Madame Curie Bioscience Database 2013. Accessed from https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK6181\/ on 1-3-2018."},{"issue":"2","key":"10.1016\/j.mehy.2018.06.019_b0300","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0306-9877(03)00331-1","article-title":"Dysautonomia in chronic fatigue syndrome: facts, hypotheses, implications","volume":"62","author":"Naschitz","year":"2004","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.mehy.2018.06.019_b0305","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/ar2212","article-title":"Dysautonomia, fibromyalgia and reflex dystrophy","volume":"9","author":"Eisinger","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.mehy.2018.06.019_b0310","first-page":"1","article-title":"Nrf2, a master regulator of detoxification and also antioxidant, anti-inflammatory and other cytoprotective mechanisms, is raised by health promoting factors","volume":"67","author":"Pall","year":"2015","journal-title":"Acta Physiol Sinica"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718303645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718303645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T06:28:30Z","timestamp":1751696910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987718303645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":62,"alternative-id":["S0306987718303645"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2018.06.019","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How chronic administration of benzodiazepines leads to unexplained chronic illnesses: A hypothesis","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2018.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}